Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Galea

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Trends in Immunology|November 30, 2006
What is immune privilege (not)?Ian Galea, Ingo Bechmann, V Hugh Perry
BMJ (Clinical Research Ed.)|April 16, 2015
Relapse in multiple sclerosisIan Galea, Nicki Ward-Abel, Christoph Heesen
Neurology|March 4, 2014
CNS inflammation other than multiple sclerosis: how likely is diagnosis?Duncan Street, Christopher A Halfpenny, Ian Galea
BMJ (Clinical Research Ed.)|January 31, 2004
Stress and exacerbations in multiple sclerosis: whether stress triggers relapses remains a conundrumIan Galea, Tracey A Newman, Yori Gidron
Trends in Immunology|December 5, 2006
What is the blood-brain barrier (not)?Ingo Bechmann, Ian Galea, V Hugh Perry
Brain, Behavior, & Immunity - Health|November 3, 2022
Systemic infection drives urgent care needs and outcome in adults with long-term neurological conditionsAna Saldanha Ramos, Ian Galea, Aravinthan Varatharaj
European Journal of Neurology|August 30, 2022
Long-term fatigue following aneurysmal subarachnoid haemorrhage and the impact on employmentBen Gaastra, Harry Carmichael, Ian Galea, et al.
Practical Neurology|October 6, 2023
Cryptococcal meningoencephalitis in multiple sclerosis treated with fingolimodMoneeb Nasir, Ian Galea, Aidan Neligan, et al.
Oxidative Medicine and Cellular Longevity|November 7, 2017
Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-AnalysisBen Gaastra, James Glazier, Diederik Bulters, et al.
Plos One|March 1, 2018
Do people with multiple sclerosis want to know their prognosis? A UK nationwide studyLaura Dennison, Martina Brown, Sarah Kirby, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Trends in Immunology|November 30, 2006
What is immune privilege (not)?Ian Galea, Ingo Bechmann, V Hugh Perry
BMJ (Clinical Research Ed.)|April 16, 2015
Relapse in multiple sclerosisIan Galea, Nicki Ward-Abel, Christoph Heesen
Neurology|March 4, 2014
CNS inflammation other than multiple sclerosis: how likely is diagnosis?Duncan Street, Christopher A Halfpenny, Ian Galea
BMJ (Clinical Research Ed.)|January 31, 2004
Stress and exacerbations in multiple sclerosis: whether stress triggers relapses remains a conundrumIan Galea, Tracey A Newman, Yori Gidron
Trends in Immunology|December 5, 2006
What is the blood-brain barrier (not)?Ingo Bechmann, Ian Galea, V Hugh Perry
Brain, Behavior, & Immunity - Health|November 3, 2022
Systemic infection drives urgent care needs and outcome in adults with long-term neurological conditionsAna Saldanha Ramos, Ian Galea, Aravinthan Varatharaj
European Journal of Neurology|August 30, 2022
Long-term fatigue following aneurysmal subarachnoid haemorrhage and the impact on employmentBen Gaastra, Harry Carmichael, Ian Galea, et al.
Practical Neurology|October 6, 2023
Cryptococcal meningoencephalitis in multiple sclerosis treated with fingolimodMoneeb Nasir, Ian Galea, Aidan Neligan, et al.
Oxidative Medicine and Cellular Longevity|November 7, 2017
Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-AnalysisBen Gaastra, James Glazier, Diederik Bulters, et al.
Plos One|March 1, 2018
Do people with multiple sclerosis want to know their prognosis? A UK nationwide studyLaura Dennison, Martina Brown, Sarah Kirby, et al.
Pageof 12